Meilleure Health International Industry Group
Market Cap
HK$2.4b
Last Updated
2021/03/05 10:18 UTC
Data Sources
Company Financials +
Executive Summary
Meilleure Health International Industry Group Limited, an investment holding company, trades in health care products, and construction and chemical materials in Hong Kong and Mainland China. More Details
Risk Analysis
Snowflake Analysis
Mediocre balance sheet with weak fundamentals.
Share Price & News
How has Meilleure Health International Industry Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 2327 is more volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: 2327's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
Market Performance
7 Day Return
9.8%
2327
-0.1%
HK Trade Distributors
-0.2%
HK Market
1 Year Return
27.3%
2327
9.3%
HK Trade Distributors
20.8%
HK Market
Return vs Industry: 2327 exceeded the Hong Kong Trade Distributors industry which returned 9% over the past year.
Return vs Market: 2327 exceeded the Hong Kong Market which returned 19.4% over the past year.
Shareholder returns
| 2327 | Industry | Market | |
|---|---|---|---|
| 7 Day | 9.8% | -0.1% | -0.2% |
| 30 Day | -6.7% | 8.5% | -1.5% |
| 90 Day | 17.9% | 7.6% | 10.3% |
| 1 Year | 27.3%27.3% | 13.2%9.3% | 25.4%20.8% |
| 3 Year | 17.9%17.9% | -41.9%-45.0% | 4.0%-6.8% |
| 5 Year | 96.4%93.1% | -45.1%-48.6% | 60.7%33.5% |
Long-Term Price Volatility Vs. Market
How volatile is Meilleure Health International Industry Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall St
Did You Miss Meilleure Health International Industry Group's (HKG:2327) Impressive 124% Share Price Gain?2 months ago | Simply Wall St
Here's What We Think About Meilleure Health International Industry Group's (HKG:2327) CEO Pay3 months ago | Simply Wall St
Will the Promising Trends At Meilleure Health International Industry Group (HKG:2327) Continue?Valuation
Is Meilleure Health International Industry Group undervalued compared to its fair value and its price relative to the market?
1.87x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate 2327's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate 2327's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: 2327 is unprofitable, so we can't compare its PE Ratio to the HK Trade Distributors industry average.
PE vs Market: 2327 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 2327's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 2327 is overvalued based on its PB Ratio (1.9x) compared to the HK Trade Distributors industry average (0.5x).
Next Steps
Future Growth
How is Meilleure Health International Industry Group forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
11.9%
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 2327's forecast earnings growth is above the savings rate (1.5%).
Earnings vs Market: Insufficient data to determine if 2327's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2327's revenue (11.9% per year) is forecast to grow slower than the Hong Kong market (13.5% per year).
High Growth Revenue: 2327's revenue (11.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2327's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has Meilleure Health International Industry Group performed over the past 5 years?
3.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 2327 is currently unprofitable.
Growing Profit Margin: 2327 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 2327 is unprofitable, but has reduced losses over the past 5 years at a rate of 3% per year.
Accelerating Growth: Unable to compare 2327's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2327 is unprofitable, making it difficult to compare its past year earnings growth to the Trade Distributors industry (-0.6%).
Return on Equity
High ROE: 2327 has a negative Return on Equity (-1.5%), as it is currently unprofitable.
Next Steps
Financial Health
How is Meilleure Health International Industry Group's financial position?
Financial Position Analysis
Short Term Liabilities: 2327's short term assets (HK$887.4M) exceed its short term liabilities (HK$184.0M).
Long Term Liabilities: 2327's short term assets (HK$887.4M) exceed its long term liabilities (HK$185.3M).
Debt to Equity History and Analysis
Debt Level: 2327's debt to equity ratio (18.5%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 2327's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 2327's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 2327 is unprofitable, therefore interest payments are not well covered by earnings.
Balance Sheet
Next Steps
Dividend
What is Meilleure Health International Industry Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 2327's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 2327's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 2327's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 2327's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 2327 is not paying a notable dividend for the Hong Kong market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 2327's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
4.6yrs
Average management tenure
CEO
Wen Chuan Zhou (37 yo)
7.5yrs
Tenure
HK$800,000
Compensation
Ms. Wen Chuan Zhou has been the Chief Executive Officer and Executive Director of Meilleure Health International Industry Group Limited (formerly known as U-Home Group Holdings Limited) since September 23,...
CEO Compensation Analysis
Compensation vs Market: Wen Chuan's total compensation ($USD103.11K) is below average for companies of similar size in the Hong Kong market ($USD330.60K).
Compensation vs Earnings: Wen Chuan's compensation has increased whilst the company is unprofitable.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Co-Chairman of the Board | 1.75yrs | HK$767.00k | 22.95% HK$ 558.9m | |
| Executive Co-Chairman of the Board | 1.75yrs | HK$220.00k | 1.76% HK$ 42.8m | |
| Vice Chairman & CEO | 7.5yrs | HK$800.00k | 0.75% HK$ 18.2m | |
| CFO & Company Secretary | 1.67yrs | no data | no data | |
| Human Resources Manager | no data | no data | no data | |
| Chief of R&D Dept - Kunming Jida Pharmaceutical Company Ltd and Director of R&D Dept - Kunming Jida | no data | no data | no data | |
| President of Jiwa Rintech Holdings Limited and Executive Director of Jiwa Rintech Holdings Limited | no data | no data | no data | |
| Quality Director of KJP and Director of Yunnan Jiwa Pharm-Tech Co Ltd | no data | no data | no data | |
| Executive Assistant to Chairman and COO of Kunming Jida Pharmaceutical Company Ltd | no data | no data | no data |
4.6yrs
Average Tenure
57yo
Average Age
Experienced Management: 2327's management team is considered experienced (4.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Co-Chairman of the Board | 1.75yrs | HK$767.00k | 22.95% HK$ 558.9m | |
| Executive Co-Chairman of the Board | 1.75yrs | HK$220.00k | 1.76% HK$ 42.8m | |
| Vice Chairman & CEO | 7.5yrs | HK$800.00k | 0.75% HK$ 18.2m | |
| President of Jiwa Rintech Holdings Limited and Executive Director of Jiwa Rintech Holdings Limited | no data | no data | no data | |
| Quality Director of KJP and Director of Yunnan Jiwa Pharm-Tech Co Ltd | no data | no data | no data | |
| Independent Non-Executive Director | 7.58yrs | HK$175.00k | 0.012% HK$ 290.7k | |
| Non-Executive Director | 5.42yrs | HK$175.00k | no data | |
| Independent Non-Executive Director | 7.58yrs | HK$175.00k | no data | |
| Independent Non-Executive Director | 1.83yrs | HK$72.00k | no data |
3.6yrs
Average Tenure
58yo
Average Age
Experienced Board: 2327's board of directors are considered experienced (3.6 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: 2327 insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Meilleure Health International Industry Group Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Meilleure Health International Industry Group Limited
- Ticker: 2327
- Exchange: SEHK
- Founded: NaN
- Industry: Trading Companies and Distributors
- Sector: Capital Goods
- Market Cap: HK$2.435b
- Shares outstanding: 4.27b
- Website: https://www.meilleure.com.cn
Number of Employees
Location
- Meilleure Health International Industry Group Limited
- Tower 1
- Unit 2906
- Admiralty
- Hong Kong
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 2327 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Ordinary Shares | HK | HKD | Oct 2003 |
Biography
Meilleure Health International Industry Group Limited, an investment holding company, trades in health care products, and construction and chemical materials in Hong Kong and Mainland China. It operates th...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/03/05 10:18 |
| End of Day Share Price | 2021/03/05 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.